Amgen's Tezspire gets FDA Approval For Self-Administration For Patients With Severe Asthma

 Amgen's Tezspire gets FDA Approval  For Self-Administration For Patients With Severe Asthma
Image source: ©2022 Kalkine Media®
                                 

Feb 2 (Reuters) - Amgen Inc:


* AMGEN - ANNOUNCED FDA APPROVED TEZSPIRE FOR SELF-ADMINISTRATION IN PRE-FILLED, SINGLE-USE PEN FOR PATIENTS AGED 12 YEARS & OLDER WITH SEVERE ASTHMA

* AMGEN INC - FDA HAS APPROVED TEZSPIRE FOR SELF-ADMINISTRATION IN U.S. WITH A NEW PRE-FILLED PEN Source text for Eikon: Further company coverage:

Disclaimer

The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Featured Articles